Format

Send to

Choose Destination
Presse Med. 2018 Oct;47(10):882-885. doi: 10.1016/j.lpm.2018.10.004. Epub 2018 Oct 25.

[Use and misuse of benzodiazepines out of France].

[Article in French]

Author information

1
Université Bordeaux, Inserm, Bordeaux Population Health Research Center, Pharmacoepidemiology research team, UMR 1219, 33000 Bordeaux, France; Centre hospitalier Charles-Perrens, 33000 Bordeaux, France; DRUGS-SAFE National Platform of Pharmacoepidemiology, France. Electronic address: mtournier@ch-perrens.fr.
2
Université Bordeaux, Inserm, Bordeaux Population Health Research Center, Pharmacoepidemiology research team, UMR 1219, 33000 Bordeaux, France; Centre hospitalier universitaire de Bordeaux, 33000 Bordeaux, France; DRUGS-SAFE National Platform of Pharmacoepidemiology, France.
3
Université Bordeaux, Inserm, Bordeaux Population Health Research Center, Pharmacoepidemiology research team, UMR 1219, 33000 Bordeaux, France; DRUGS-SAFE National Platform of Pharmacoepidemiology, France.

Abstract

Among 8 countries included in the report of ANSM, France is second behind Spain, when defined daily doses (DDD) are considered. Few studies, recent and based on representative samples of population, investigated the use of benzodiazepines in other countries and data are limited to compare France and other countries. In most countries, the use of benzodiazepines increases with age and is more frequent in women than in men. Variations of benzodiazepines use that were observed in other countries are similar to those observed in France, with a slight decrease but persistent high levels of use. In most countries, the long-term use of benzodiazepines is stable over time even though simple use decreases.

PMID:
30454580
DOI:
10.1016/j.lpm.2018.10.004
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center